Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3D72S | SC |
patient given MMR(Priorix) that was frozen prior to reconstitution; Priorix received to 63 years patient; This non-serious case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 63-year-old female patient who received MMR (Priorix) (batch number 3D72S, expiry date 01-SEP-2025) for prophylaxis. Concomitant products included Priorix. On 07-JAN-2025, the patient received Priorix (subcutaneous) .5 ml. On 07-JAN-2025, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: Priorix received to 63 years patient). On an unknown date, the patient experienced incorrect storage of drug (Verbatim: patient given MMR(Priorix) that was frozen prior to reconstitution). The outcome of the incorrect storage of drug and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-APR-2025 Healthcare Provider stated they stored Priorix in the freezer instead of the fridge and lowest temperature reached would be probably minus 17 degrees Fahrenheit and the vaccine was administered after the temperature excursion, which led to incorrect storage of vaccine. Caller did not have any patient demographics or dates of administration. The Priorix administered to 63 years patient which led to inappropriate age at vaccine administration. The reporter consented to follow up. Reporter stated that patient given Mmr (Priorix) that was frozen prior to reconstitution.; Sender's Comments: US-GSK-US2025034230:Same reproter diffrent patient
Priorix